IPT at Interphex 2010

By Claire Videau and Gareth Macdonald

- Last updated on GMT

Related tags: New york city, Pharmacology

Next week in-Pharmatechnologist heads for the excitement, energy and razamatazz of New York, US and Interphex 2010.

We’re going to the big apple to join the 13,000 industry professionals and 700 plus exhibitors expected to attend to report on all the new drug manufacturing technologies and innovations showcased at the event.

Our team will visit every corner of the Jacob K Javits convention centre to ensure we cover all the breaking industry news in our own innovate “as-it-happens” style.

From text articles to tweets, to videos and podcasts we’ll bring you the key facts, figures and developments in the online format that suits you and the rapidly evolving pharmaceutical sector.

This year’s exhibition comprises dedicated industrial zones, bringing together thought leaders in everything from plant automation and packaging technologies to drug ingredient sourcing and manufacturing.

We’re particularly excited about visiting the new facilities area and speaking with the key opinion formers and innovators in pharmaceutical manufacturing plant design, construction and development.

And, while tracking down all the breaking news is always our focus, we’re also keen to meet the drug industry and invite you to come say hello to the editorial team at booth number 837.

But, whether you’re going to Interphex this year or not, you’ll find in-pharmatechnologist’s news coverage delivery direct to you inbox every morning, helping you to stay in touch with the developments that matter.

Related news

Show more

Related products

show more

Accelerate your supply chain as pressures intensify

Accelerate your supply chain as pressures intensify

William Reed | 17-Sep-2018 | Technical / White Paper

Food, Drink and Non-Food manufacturers are under pressure. Range reviews, massive retail mergers, the backlash against plastic packaging and the ongoing...


NEW…sugarcane derived USP Squalane from Aprinnova

APRINNOVA – A joint venture of AMYRIS and NIKKOL Group | 26-Feb-2018 | Product Brochure

To date, topical formulation chemists have been restricted to using Squalane derived from the harvesting of shark livers. Neossance Squalane USP, derived...

Related suppliers

Follow us


View more